Press release content from Business Wire. The AP news staff was not involved in its creation.

Urinalysis Market Size, Share & Trends Analysis Report 2022: A $5.4 Billion Market by 2030 - Focused Research on Disease Screening, Pregnancy & Fertility Testing -

PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.
January 4, 2023 GMT

DUBLIN--(BUSINESS WIRE)--Jan 4, 2023--

The “Urinalysis Market Size, Share & Trends Analysis Report by Product, by Application (Disease Screening {UTI, Kidney Disease}, Pregnancy & Fertility Testing), by End-use, by Region, and Segment Forecasts, 2022-2030” report has been added to’s offering.

The global urinalysis market size is expected to reach USD 5.4 billion by 2030.

The market is expected to witness a CAGR of 4.6% from 2022 to 2030. Increasing incidence of UTI worldwide contributes to market growth. According to a study published by SHEA journal, in 2021, approximately 60% to 70% of urinalyses were being performed in patients without symptoms referable to the Gastrointestinal Tract (GU).

Increasing geriatric population and the subsequent increase in age related diseases in developed and developing regions will positively influence urinalysis market growth. According to the World Health Organization (WHO), the geriatric population increased from 1 billion in 2020 to 1.4 billion in 2021.


The early diagnosis and management of chronic diseases in geriatric population is responsible for the increasing prescription rate for tests such as bilirubin, ketones, glucose, and creatinine. These tests are performed by urinalysis; hence, it is anticipated to drive market growth.

Moreover, for patients undergoing transplant surgeries including kidney and liver, transplant procedures is often recommended to undergo preoperative urinalysis to avoid urinary tract infections (UTIs). According to United Network for Organ Sharing data, around 24,669 kidney transplants, 9,236 liver transplants, and 3,817 heart transplants were performed in the U.S. in 2021. Thus, an increasing number of transplant surgeries is expected to fuel market growth.

Companies are taking initiatives such as collaboration and strategic partnerships for the development and marketing of technologically advanced urinalysis products. For instance, in October 2021, Sysmex entered into collaboration with Inpeco for the development of an automated urinalysis workflow solution of the highest level.

This product was developed with a help of UN-Series of Sysmex’s and FlexLab TM track of Inpeco’s urinalysis solutions. It is the only fully open automation system that helps laboratories optimize their workflow support and provide premium patient care.


Urinalysis Market Report Highlights

  • Based on product, the consumables segment held the largest share market in 2021 due to wider usage of dipsticks due to their efficiency coupled with lost costs
  • Based on application, the disease screening segment accounted for the largest segment, owing to the increasing prevalence of target diseases such as UTI, kidney disease, and liver disease, along with the rising application of urinalysis for screening of these diseases
  • On the basis of end-use, the clinical laboratories segment dominated the market in 2021 owing to higher patient footfall in clinical laboratories for urine testing for disease diagnosis
  • Home care segment is expected to witness significant growth over the forecast period owing to increasing investment for the development of home-based urine testing kits for disease diagnosis
  • North America segment dominated the market in 2021 due to favorable reimbursement policies, rising incidence of UTI, well-established healthcare infrastructure, and supportive regulatory reforms


Market Variables, Trends, & Scope

Market driver analysis

  • Increasing prevalence of target diseases
  • Introduction of technologically advanced diagnostics
  • Growing base of geriatric population
  • Introduction of CLIA waived tests

Market restraint analysis

  • Lack of healthcare infrastructure
  • Presence of ambiguous regulatory framework

Porter’s five forces analysis

PESTEL Analysis

Pipeline Analysis

Competitive Analysis

  • Abbott
  • Sysmex Corporation
  • Acon Laboratories, Inc.
  • Bio-Rad Laboratories, Inc.
  • Arkray Inc.
  • F. Hoffmann-La Roche Ltd
  • Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
  • Siemens Healthcare GmbH
  • Quidel Corporation

For more information about this report visit


About is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on


Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900



SOURCE: Research and Markets

Copyright Business Wire 2023.

PUB: 01/04/2023 10:49 AM/DISC: 01/04/2023 10:49 AM